Corbus Pharmaceuticals Holdings (CRBP) Other financing activities (2015 - 2017)
Corbus Pharmaceuticals Holdings' (CRBP) quarterly Other financing activities came in at $80248.0 in Q1 2017, down 55.28% quarter-over-quarter from $179443.0 in Q3 2016.
Corbus Pharmaceuticals Holdings (CRBP) Other financing activities (2015 - 2017) Analysis & Trends
Corbus Pharmaceuticals Holdings' Other financing activities history runs 3 years deep, the most recent figure standing at $80248.0 for Q1 2017.
- On a quarterly basis, Other financing activities changed N/A year-over-year to $80248.0 in Q1 2017; TTM through Mar 2017 was $6.7 million, a N/A change from a year earlier, with the FY2015 full-year figure at $10.8 million, changed N/A from the prior year.
- Other financing activities fell to $80248.0 in Q1 2017 per CRBP's latest filing, from $179443.0 in the prior quarter.
- Across five years, Other financing activities topped out at $6.4 million in Q3 2015 and bottomed at $80248.0 in Q1 2017.
- The 3-year median for Other financing activities is $179443.0 (2016), against an average of $2.2 million.
- Biggest YoY gain for Other financing activities was 97.2% in 2016; the steepest drop was 97.2% in 2016.
- Year by year, Other financing activities stood at $6.4 million in 2015, then sank by 97.2% to $179443.0 in 2016, then sank by 55.28% to $80248.0 in 2017.
- Per Business Quant, the three latest CRBP Other financing activities figures stand at $80248.0 (Q1 2017), $179443.0 (Q3 2016), and $6.4 million (Q3 2015).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 164.14 Mn | 136.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 80,248.00 |
| Mar 31, 2017 | 80,248.00 |
| Sep 30, 2016 | 179,443.00 |
| Sep 30, 2016 | 179,443.00 |
| Sep 30, 2015 | 6.42 Mn |
| Sep 30, 2015 | 6.42 Mn |